Zurcher Kantonalbank Zurich Cantonalbank Acquires 1,253 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Dolby Laboratories, Inc. (NYSE:DLBFree Report) by 11.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,652 shares of the electronics maker’s stock after purchasing an additional 1,253 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Dolby Laboratories were worth $1,090,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of DLB. VisionPoint Advisory Group LLC boosted its stake in Dolby Laboratories by 86.9% during the third quarter. VisionPoint Advisory Group LLC now owns 370 shares of the electronics maker’s stock worth $29,000 after buying an additional 172 shares during the period. Blue Trust Inc. boosted its stake in Dolby Laboratories by 75.7% during the fourth quarter. Blue Trust Inc. now owns 369 shares of the electronics maker’s stock worth $29,000 after buying an additional 159 shares during the period. Fifth Third Bancorp boosted its stake in Dolby Laboratories by 175.3% during the third quarter. Fifth Third Bancorp now owns 446 shares of the electronics maker’s stock worth $35,000 after buying an additional 284 shares during the period. Platinum Investment Management Ltd. purchased a new position in Dolby Laboratories during the third quarter worth $109,000. Finally, Column Capital Advisors LLC boosted its stake in Dolby Laboratories by 20.1% during the third quarter. Column Capital Advisors LLC now owns 1,462 shares of the electronics maker’s stock worth $116,000 after buying an additional 245 shares during the period. Institutional investors own 58.56% of the company’s stock.

Analyst Upgrades and Downgrades

DLB has been the subject of a number of recent analyst reports. StockNews.com raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Rosenblatt Securities reissued a “buy” rating and set a $98.00 target price on shares of Dolby Laboratories in a research note on Wednesday, January 31st.

Read Our Latest Analysis on DLB

Dolby Laboratories Trading Down 0.9 %

Shares of DLB opened at $79.20 on Friday. Dolby Laboratories, Inc. has a 12-month low of $75.87 and a 12-month high of $91.01. The firm has a fifty day moving average price of $81.62 and a 200-day moving average price of $83.31. The firm has a market capitalization of $7.57 billion, a P/E ratio of 41.04 and a beta of 0.97.

Dolby Laboratories (NYSE:DLBGet Free Report) last released its quarterly earnings data on Thursday, February 1st. The electronics maker reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.14. Dolby Laboratories had a net margin of 14.70% and a return on equity of 10.21%. The company had revenue of $315.57 million during the quarter, compared to analyst estimates of $310.98 million. Analysts predict that Dolby Laboratories, Inc. will post 2.6 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 22nd. Investors of record on Tuesday, February 13th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Monday, February 12th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 62.18%.

Insider Buying and Selling

In other Dolby Laboratories news, SVP John D. Couling sold 33,560 shares of the business’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.81, for a total value of $2,711,983.60. Following the completion of the transaction, the senior vice president now directly owns 108,519 shares in the company, valued at $8,769,420.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 39.54% of the stock is owned by insiders.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.